Medco Downplays Competition From Health Plans’ In-House PBMs
Executive Summary
Pharmacy benefit manager subsidiaries of large health insurers lack the scale and capability to provide the kinds of cost benefits and services offered by the big stand-alone PBMs, Medco Health Solutions Chairman David Snow maintains
You may also be interested in...
Vytorin/Zetia Rx Decline Prompts Schering-Plough To Issue Monthly Updates
Schering-Plough says it will soon start providing monthly updates on prescription rates for its two cholesterol drugs Vytorin (ezetimibe/simvastatin) and Zetia (ezetimibe) to help ease the minds of anxious investors
Warfarin Dosing Issues Emerge In Early Results From Medco/Mayo Research
Nearly three-fourths of early patient participants in a warfarin research project appear to need non-standard dosing of the drug based on genetic screening, Medco reported during its analyst day presentation Nov. 16
Medco PolyMedica Acquisition Expands Medicare Foothold Into Part B
Medco will establish a presence in Medicare Part B with its $1.5 billion purchase of diabetes services provider PolyMedica